| Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
| Journal website http://www.jofem.org |
Original Article
Volume 8, Number 5, October 2018, pages 100-105
Evaluation of Clinical and Microbiological Characteristics of Foot Infections of Patients With Diabetes: Does Antibiotic Susceptibility Change?
Tables
| N (%) | Mean ± SD | |
|---|---|---|
| *No patients in Wagner stages 0 and 1. | ||
| Age (year) | 63.1 ± 10.9 | |
| Duration of diabetes (year) | 16.9 ± 6.9 | |
| Gender | ||
| Female | 12 (23.5%) | |
| Male | 39 (77.5%) | |
| Neuropathy | 50 (98%) | |
| Nephropathy | 44 (86%) | |
| Retinopathy | 48 (94%) | |
| Peripheral arterial disease | 40 (78.4%) | |
| Wagner stage* | ||
| Wagner 2 | 5 (9.6%) | |
| Wagner 3 | 33 (63.5%) | |
| Wagner 4 | 14 (26.9%) | |
| Osteomyelitis | 47 (90.4%) | |
| Amputation | 46 (90.1%) | |
| Bacteria | Total (N) |
|---|---|
| Gram-positive microorganisms | 96 |
| Enterococcus faecalis | 28 |
| Staphylococcus aureus | 23 |
| Staphylococcus epidermidis | 18 |
| Other CNS | 9 |
| Streptococcus agalactiae | 8 |
| Streptococcus dysgalactiae | 4 |
| Streptococcus viridans | 3 |
| Enterococcus avium | 2 |
| Streptococcus pyogenes | 1 |
| Gram-negative microorganisms | 101 |
| Pseudomonas aeruginosa | 16 |
| Morganella morganii | 15 |
| Escherichia coli | 13 |
| Acinetobacter baumannii | 11 |
| Proteus mirabilis | 11 |
| Serratia marcescens | 6 |
| Klebsiella pneumoniae | 5 |
| Citrobacter koseri | 4 |
| Providencia rettgeri | 3 |
| Klebsiella oxytoca | 2 |
| Citrobacter braakii | 2 |
| Citrobacter freundii | 2 |
| Enterobacter cloacae | 2 |
| Stenotrophomonas maltophilia | 3 |
| Proteus penneri | 1 |
| Proteus vulgaris | 1 |
| Providencia alcalifaciens | 1 |
| Providencia stuartii | 1 |
| Serratia liquefaciens | 1 |
| Sphingomonas paucimobilis | 1 |
| Fungi | |
| Candida species | 1 |
| Total | 207 |
| Characteristic of reproduction | Number (N) | Amputation N (%) | Osteomyelitis N (%) |
|---|---|---|---|
| Mono microbial | 85 | 74 (87%) | 54 (64%) |
| Gram-positive | 43 | ||
| Gram-negative | 42 | ||
| Poly microbial | 54 | 52 (98%) | 40 (75%) |
| All are Gram-positive | 12 | ||
| All are Gram-negative | 7 | ||
| Mixed | 35 |
| Microorganism | Type of resistance | Resistance (N)/total (N) (%) |
|---|---|---|
| In S. aureus | ||
| Methicillin resistance | 5/11 (45%) | |
| Quinolone resistance | 7/20 (35%) | |
| TMP/SMX resistance | 2/15 (13%) | |
| Clindamycin resistance | 7/15 (47%) | |
| In CNS | ||
| Methicillin resistance | 19/22 (86%) | |
| In Enterobacteriaceae | ||
| ESBL positivity | 5/12 (42%) | |
| Quinolone resistance | 25/34 (74%) | |
| P. aeruginosa | ||
| Carbapenem resistance | 6/17 (35%) | |
| Quinolone resistance | 6/15 (40%) | |
| Aminoglycoside resistance | 3/15 (20%) | |
| In Enterococcus species | ||
| Ampicillin resistance | 12/30 (40%) | |
| Vancomycin resistance | 0/27 (0%) | |
| In A. baumannii | ||
| Carbapenem resistance | 8/11 (73%) | |
| Aminoglycoside resistance | 6/11 (55%) |